MedTrace Logo

Examining the Generality of Laboratory-based Findings and Their Moderators in the ITC Study

NCT06456671 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 440

Last updated 2026-04-22

Study results available
· View outcomes & findings →

Summary

This study will investigate the relative appeal (abuse liability) of novel tobacco products, how the appeal is modulated by relative price, user type, and how novel products may substitute for one another.

Conditions

  • Cigarette Smoking
  • Nicotine Vaping

Interventions

OTHER

All nicotine/ tobacco products at market price

Nicotine/tobacco products available in the Experimental Tobacco Marketplace at market price. Note that all participants will complete all the specified conditions.

OTHER

Nicotine vaping products at 1/2 market price

Availability of nicotine vaping products in the Experimental Tobacco Marketplace at 1/2 market price. Other nicotine/tobacco products at market price. Note that all participants will complete all the specified conditions.

OTHER

Heated tobacco products at 1/2 market price.

Availability of heated tobacco products in the Experimental Tobacco Marketplace at 1/2 market price. Other nicotine/tobacco products at market price. Note that all participants will complete all the specified conditions.

OTHER

Nicotine pouch products at 1/2 market price.

Availability of heated tobacco products in the Experimental Tobacco Marketplace at 1/2 market price. Other nicotine/tobacco products at market price. Note that all participants will complete all the specified conditions.

Sponsors & Collaborators

  • Medical University of South Carolina

    collaborator OTHER

  • University of Waterloo

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • Virginia Polytechnic Institute and State University

    lead OTHER

Principal Investigators

  • Warren K Bickel, Ph.D. · Fralin Biomedical Research Institute at VTC

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-29
Primary Completion
2025-01-07
Completion
2025-01-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06456671 on ClinicalTrials.gov